Recent studies have shown that pigs could donate hearts and kidneys for people. But livers, which rely on enzymes specific to each species, are more difficult. Now comes a promising new approach: partly humanize the pig’s liver. Researchers at Ximerex in Omaha, Neb., infused human liver cells into fetal pigs and watched the cells produce human liver enzymes. But with no room in the pigs’ livers, the human cells ended up in the spleen. To solve this space problem, Ximerex is developing genetically modified pigs programmed to kill off 20 to 80 percent of their own liver cells. The next step will be to transfer the pigs’ immune cells to the patient to build up a tolerance of the hybrid organ. Working with the University of Nebraska, Ximerex hopes to begin human trials in 2005, says President William Beschorner.
This startup wants to copy you into an embryo for organ harvesting
With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.
VR is as good as psychedelics at helping people reach transcendence
On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
This artist is dominating AI-generated art. And he’s not happy about it.
Greg Rutkowski is a more popular prompt than Picasso.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.